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Abstract
Background:  Benign neutropenia, i.e., neutropenia not associated with an increased risk of
infection, may result in serious medical consequences when a 'standard' definition of neutropenia
(absolute neutrophil count (ANC) < 1.5 × 109cells/L) is universally applied to all races. The aims of
this study were to determine the prevalence of benign neutropenia among healthy Arabs and
evaluate its mode of inheritance.
Methods: ANCs were studied prospectively amongst a healthy indigenous population (n = 1032)
from the United Arab Emirates undergoing a nation-wide sickle-cell and thalassemia screening
program. The mean neutrophil count and the prevalence of benign neutropenia were compared by
age, sex and amongst various tribes.
Results: The mean neutrophil count (× 109cells/L) was 3.3 (range 0.95–7.6). Benign neutropenia
was present in 110 (10.7%) subjects of whom 24 (2.3%) individuals had moderate neutropenia
(ANC 0.5 – 1.0 × 109 cells/L). In the 22 tribe-family groups, the prevalence of benign neutropenia
varied between 0% and 38%. Benign neutropenia showed no difference in the frequency amongst
the sexes (p = 0.23) and it was independent of age (Spearman's rho = 0.05, p = 0.13). The age-
related mean neutrophil count was the lowest in Arabs when compared with other ethnic groups
(Blacks, Europeans and Mexicans). The inheritance of benign neutropenia was consistent with an
autosomal dominant pattern; however, the diversity of observed phenotypes suggested the
presence of more than one genetic variant for this trait.
Conclusion: Arabs have a high prevalence of benign neutropenia that may be inherited as an
autosomal dominant trait.
Background
Neutropenia is defined as an absolute neutrophil count
(ANC) of less than 1.5 × 109 cells/L. During the second
half of the 20th century, this cutoff value was derived from
clinical trials which were evaluating the myelosuppressive
effects of chemotherapy. Most patients recruited for these
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seminal studies were of European origin; subsequently, it
was realized that this 'standard' caused an excessive
number of healthy individuals of African descent to be
mislabeled as neutropenic. The neutropenia that is not
associated with an increased risk of infections has been
called benign neutropenia (BN). Using this description,
BN has been reported in up to 30% of people of African
origin [1]. Recently, the prevalence of neutropenia in
American Blacks was found to be 4.4% compared to 0.8%
in Whites [2]. Acquired chronic idiopathic neutropenia,
which uses a higher cutoff for the neutrophil count and is
related to inflammation, should be distinguished from
ethnic BN [3,4].
This blanket definition of neutropenia may have serious
implications in clinical practice. In patients on myelosup-
pressive therapy, the infectious complications of neutro-
penia are prevented by reducing the drug dose that is
dependent on the neutrophil nadir. Thus, BN in healthy
Blacks may cause an inappropriate reduction of the dose
of the chemotherapeutic agent with serious consequences.
It is possible that the poorer survival of black women with
breast cancer may be partly due to this fact [5,6]. The anti-
schizophrenia drug clozapine, which often causes neutro-
penia, is more likely to be discontinued in Blacks than
Whites [7]. Similarly, the drug is less often initiated in
Blacks due to a fear of the dreaded agranulocytosis [8].
There are other potential problems in subjects with BN
which may occur: an unnecessary use of antibiotics for
febrile non-bacterial illnesses and inappropriate hemato-
logical investigations. As in Blacks with BN, other ethnic
groups known to have a 'low' neutrophil count (e.g., Yem-
eni and Ethiopian Jews) may be exposed to the same risks
[9,10]. In Arabs, the reference range for neutrophil count
has not been established; therefore, the prevalence of BN
is unknown. Some reports suggest that Arabs also may
have a lower neutrophil count when compared to people
of European descent [10-12]. Arabs comprise of approxi-
mately 300 million people from 29 countries; they often
live in tribal groups and practice endogamy, a custom that
could alter the prevalence of genetic conditions like BN.
Therefore, establishing reference values of normal neu-
trophil counts in healthy Arabs is very important to pre-
vent any potential harm arising from an inappropriate
reference range. The aims of this study were a) to deter-
mine the prevalence of BN (i.e., ANC < 1.5 × 109 cells/L)
in an unbiased sample of healthy Arabs, b) to analyze
dynamics of neutrophil count in subjects with BN, and c)




Blood samples were drawn (once) over a six-month
period (March, 2007 – August, 2007) as part of a nation-
wide population-screening program for thalassemia and
hemoglobin S. This screening center is located in the city
of Al Ain, United Arab Emirates (UAE), which is on the
border with Oman and in close proximity to Saudi Arabia.
This screening program is mandated and fully funded by
the government. It is restricted to the citizens of the UAE
who intend to marry; therefore, the expatriate population
was excluded from this study. In the local UAE popula-
tion, marriages are arranged, often consanguineous, i.e.,
between cousins, and cannot proceed without a judge
issuing a wedding-license after verifying the screening
center report. There were no exclusion criteria, but data
was missing in 47 (4.5%) individuals, who could not be
used; the remaining 1032 consecutive healthy men and
women were included in the final analysis.
The population is strictly tribal, with a total of 67 tribes in
the country (as per 1968 population census) [13]. The
tribe, subtribe, and family group allegiance of 78% of sub-
jects was successfully determined from their last names.
Members of at least four of the tribes in this study inhabit
territories of other four Gulf countries because until very
recently there were no barriers to the movement of people
in this region.
A second cohort comprising of seven subjects with BN
were from hematology clinic; they were used in analysis of
the phenotype and the pattern of inheritance of neutrope-
nia trait. In these subjects, the diagnosis of BN was based
on 1) the negative history of use of medications known to
cause neutropenia, 2) absence of chronic diseases associ-
ated with neutropenia, 3) absence of infection, 4) normal
physical examination. Moreover, the laboratory tests con-
firmed the absence of anemia, thrombocytopenia and
anti-nuclear antibodies, normal B12 and folate levels, nor-
mal bone marrow examination (in three of seven sub-
jects) and documented neutropenia in at least one family
member (in six of seven subjects). In all seven subjects,
neutrophil counts were obtained from their medical
records. Additionally, in two brothers with multiple ANC
< 0.5 × 109 cells/L but without recurrent infections, we
excluded a mild form of congenital neutropenia by
excluding the presence of the mutations at ELA2 and
HAX1 locus [14,15].
Ethical Approval
This study was approved by Al Ain Medical District
Human Research Ethics Committee (Protocol # 07/123).
Laboratory Methods
The complete blood count (CBC) was performed once on
every individual after the blood was collected in a tube
containing EDTA and analyzed using the Cell-Dyn Sap-
phire (Abbot Diagnostics, USA) analyzer. The hospital
laboratory subscribes to an overseas external quality con-BMC Blood Disorders 2009, 9:3 http://www.biomedcentral.com/1471-2326/9/3
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trol from the United Kingdom (UK National External
Quality Assessment Scheme). The standard deviation
index of leukocyte counts varied from -0.77 to 1.33 from
the target mean value during the study period. Hence, the
laboratory met the analytical standards for CBC.
Statistical Methods
Data were logged into a computer database and analyzed
using SPSS ver.15 for Windows (SPSS Inc., Chicago, Ill.,
USA). Standard descriptive and analytical statistical meth-
ods, such as histograms, scatter plots, linear regression
and independent samples t-tests, Spearman's and Pear-
son's correlation coefficient were used. In addition, the
ranges of cell counts were determined by taking the mean
± 2 SD on a Box-Cox (power) transformed scale and back
transformation of the normal range limits. The figures
were plotted using the SPSS and Excel (Microsoft). The
level of statistical significance was 0.05.
Results
The characteristics of 1032 subjects, their differential leu-
cocyte count and the prevalence of neutropenia are shown
in Table 1; there was no significant statistical difference in
any of these parameters between the sexes and age groups.
All 24 subjects with ANC<1.0 × 109 had normal hemo-
globin and platelet counts; therefore, hematological dis-
orders causing the marked neutropenia was unlikely. The
histogram of neutrophil counts is shown in Figure 1. In 22
largest population groups (defined by tribe, subtribe or
family allegiance), the prevalence of neutropenia varied
between 0% and 38% (Fig 2). A non-Arab tribe, which
immigrated to Arabian Peninsula a few centuries ago
(group 6 in Fig 2), had no neutropenic subjects as well as
six Arab tribe-family groups. In our study cohort, the neu-
trophil and monocyte counts were positively correlated
(Pearson's r = 0.43) (Fig 3). The subjects with neutropenia
had a significantly lower monocyte counts than subjects
without neutropenia (p < 0.001).
In seven subjects with BN from the hematology clinic,
ANC was analyzed in more detail. In contrast to 1032
study subjects from the general population among whom
none had an ANC < 0.5 × 109 cells/L, six of seven clinic
subjects had "agranulocytic" neutropenia at least once; all
seven, however, had ANC in the normal range once or
more often (Fig 4 and 5). In order to better characterize
the phenotype of BN in these patients, examination of
ANC (sorted in ascending order in Figure 4) suggested the
possibility of a mild neutropenia (in patients 2 and 3),
more profound neutropenia (in patients 4 and 7) and
possibly a cycling neutropenia (in patients 3 and 6 in Fig-
ure 5). Finally, to determine the Mendelian mode of
inheritance, the pedigrees of the four families with BN
Neutrophil count (n = 1032) Figure 1
Neutrophil count (n = 1032).
Prevalence of neutropenia in 22 tribe-family groups Figure 2
Prevalence of neutropenia in 22 tribe-family groups.
Correlation of monocyte and neutrophil count in 1032 sub- jects Figure 3
Correlation of monocyte and neutrophil count in 
1032 subjects.BMC Blood Disorders 2009, 9:3 http://www.biomedcentral.com/1471-2326/9/3
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were plotted in Figure 6. They are all consistent with auto-
somal dominant mode of inheritance of BN.
Discussion
Prevalence of neutropenia
There is a paucity of data on neutropenia amongst Arabs.
In this study, the prevalence of BN (ANC < 1.5 × 109 cell/
L) and marked neutropenia (ANC 0.5 – 1.0 × 109 cell/L)
in Arabs is 10.7% and 2.3% respectively. As the subjects
with BN periodically have ANC in the normal range (Fig
4 and 5), the observed prevalence of BN in the studied
population of Arabs may well be an underestimate. The
mean neutrophil count in Arabs is 3.3 × 109/L (range,
0.95–7.6), without any significant difference between the
sexes. As ethnicity is known to affect neutrophil count, we
compared the mean neutrophil count of the Arab subjects
in this study, of mainly young adults, with those previ-
ously reported in American Blacks, Whites and Mexicans
[2]. In Arabs, ANC is lower than the mean neutrophil val-
ues earlier reported for younger (age <18 years) and older
(age ≥ 18 years) American Mexicans, Whites and older
Blacks [2], as is shown by plotting neutrophil counts by
age for these ethnic groups (Fig 7).
In this study, the neutrophil count correlated with the
monocyte count (r = 0.43). This has not been previously
reported and is in contrast to patients with congenital
neutropenia who often show a relative increase in mono-
cytes counts. The association of neutropenia and monocy-
topenia may imply that subjects with BN may also be
monocytopenic. This may give a possible clue to its origin.
For example, in cyclic congenital neutropenia, synchro-
nized oscillation of neutrophils and monocytes may be
related to a back loop inhibition from neutrophils to their
common precursor cell [16]. Therefore, a concordant
decrease of neutrophils and monocytes may suggest that
the mechanism may involve a common progenitor cell.
In this study, there was no sex bias as there were equal
numbers of healthy males and females. A study of a
benign genetic condition in a population that is shortly
going to reproduce is most useful for estimating its preva-
lence. Similarly, there was no selection bias as the blood
tests in the study were mandatory without any cost to the
subjects; further, we identified 73 different tribes, sub-
tribes and family groups. However, the parameters which
may increase neutrophil count, e.g., smoking were not
controlled for in the study.
Our findings confirm and extend previous reports on neu-
tropenia in the Arab Peninsula. BN has been previously
reported in Jordanians and Bedouin Arabs (from the
north of Arabian Peninsula), Kuwaiti citizens (in central
part of Peninsula) as well as among Yemeni and Ethio-
pian Jews (many residing in southern part of the Penin-
sula), and amongst Arab tribe of Sudanese origin residing
in the Middle East [9-12]. In addition, four of the tribes
with neutropenia in our study are present in four other
Arab Gulf countries. This suggests that a high prevalence
of BN is likely to be present in most populations in the
Middle East and North Africa.
Phenotype of benign neutropenia
In the second part of the study, to determine the pheno-
type of BN, we analyzed seven subjects from the hematol-
ogy clinic. We sorted (in ascending order) all available
ANC of these patients, which suggested three possible
phenotypes of BN: mild, profound and cycling types of
neutropenia. This classification is tentative due to a lim-
ited number and irregularity of data points as well as
cycling of neutrophil counts in normal subjects and una-
voidable background noise [17,18]. Nonetheless, in sev-
eral subjects the impressive part was the benign nature of
the condition (absence of infections) even when ANC was
< 0.5 × 109 cells/L. In one family, two healthy sons had fre-
quently ANC < 0.5 × 109cells/L and a mild form of con-
genital neutropenia was exclude with the negative tests for
mutation at ELA2 and HAX1 gene locus. In contrast to the
absence of severe neutropenia in 1032 screened individu-
als, its presence in six clinic patients could be explained by
a larger number of measurements of ANC, selection bias,
possible effects of less frequent alleles or homozygosity
(codominant inheritance), alone or in combination.
The results of this study imply that Arabs have two healthy
subpopulations with different ANCs. How big these sub-










Leucocytes (× 109/L) 6.7 (3.5–11.5)
Neutrophils (× 109/L) 3.3 (0.95–7.6)
Lymphocytes (× 109/L) 2.6 (1.4–4.4)
Monocytes (× 109/L) 0.5 (0.3–0.9)
Eosinophiles (× 109/L) 0.17 (0.02–0.5)
Basophiles (× 109/L) 0.03 (0.01–0.08)
ANC < 1.5 × 109/L 10.7%
ANC < 1.0 × 109/L 2.3%
* Mean ± 2 SD
ANC, absolute neutrophil countBMC Blood Disorders 2009, 9:3 http://www.biomedcentral.com/1471-2326/9/3
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Dynamics of the neutrophil count in six patients (Pt) with benign neutropenia sorted in ascending order Figure 4
Dynamics of the neutrophil count in six patients (Pt) with benign neutropenia sorted in ascending order. Period 
on x-axis indicates duration of observation.BMC Blood Disorders 2009, 9:3 http://www.biomedcentral.com/1471-2326/9/3
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groups are is unclear because of a high variability of neu-
trophil count and a need for multiple sampling in order
to properly classify all the subjects. Nonetheless, in clini-
cal practice this requires two cutoff values for neutrope-
nia, one of 1.0 × 109  cells/L and perhaps less for
neutropenic population and another of 1.5 × 109 cells/L
for non-neutropenic subpopulation. The use of a single
value of ANC for defining neutropenia in such a popula-
tion would also endanger a healthy subpopulation with a
higher neutrophil count; it would be put at risk of over-
treatment with chemotherapy, under-investigation of
neutropenia or under-utilization of antibiotics for infec-
tions. Therefore, identification of healthy subjects with
lower neutrophil count through screening may be
required in this population.
Inheritance and population genetics of benign 
neutropenia
Earlier report suggested that BN in an Arab tribe is inher-
ited as autosomal dominant trait. In that report, however,
ANC < 2.0 × 109/L was used as a definition of neutropenia
[10]. Our analysis of four families using ANC < 1.5 × 109/
L as a cutoff value for neutropenia supports autosomal
dominant mode as a likely pattern of Mendelian inherit-
ance (Fig 6). However, observation of a profound neutro-
penia in several subjects (Figs 4 and 5) suggests possibility
of the existence of a more than one mutation for BN in
this population.
An indication that BN may be inherited as an "ancient"
and widely spread trait comes from the presence of neu-
Dynamics of the neutrophil count in three patients (Pt) with benign neutropenia in actual time sequence Figure 5
Dynamics of the neutrophil count in three patients (Pt) with benign neutropenia in actual time sequence. Ticks 
on x-axis are weeks.BMC Blood Disorders 2009, 9:3 http://www.biomedcentral.com/1471-2326/9/3
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tropenia in diverse Arab tribes (Fig 2). As endogamy was
strictly enforced and inter-tribe marriages were infrequent
in the past, the presence of neutropenia in many tribes
suggests that its presumed gene was present long before
tribal partitioning. In the more recent past, a more intense
mixing of people than commonly presumed is evidenced
by both historical analysis of migrations and high diver-
sity of alpha-thalassemia mutations in these populations
[13,19]. The observed variations in the prevalence of neu-
tropenia, however, could be due to a sample size, founder
effect, and different rates of expansion and mixing of pop-
ulations. The effect of widespread consanguinity
(increased homozygosity due to inbreeding) on BN could
be determined only after a better phenotype-genotype
correlation is established. Finally, that BN may be ubiqui-
tous in Arabs is suggested by a high prevalence of neutro-
penia in people of African origin; being neighbors they
could have exchanged genes during their long and com-
mon history. However, the purpose, adaptive value and
evolutionary origins of BN still need to be addressed.
Malaria hypothesis
It may be possible that the inter-ethnic differences in neu-
trophil counts may be the consequence of human adapta-
tion to malaria, similar to the thalassemias and
hemoglobin S. We base this speculation on three epidemi-
ological observations. First, there is a superimposition of
the distribution of Plasmodium falciparum and the geo-
graphic distribution of populations with low neutrophil
counts. Second, there is an inverse correlation between
the intensity of exposure to Plasmodium falciparum and the
mean neutrophil count in the same population. Histori-
cally (before Columbus), Mexicans were never exposed to
malaria and have the highest mean neutrophil count (Fig
7) and the lowest prevalence of neutropenia (0.4%) [2].
In contrast, the Arabs and Africans have a long history of
endemic malaria and both have low mean neutrophil
count and a high prevalence of neutropenia of 10.7% and
4.4%, respectively [1,2]. Similarly, ANCs are lower in
Yemeni and Ethiopian Jews, who both reside in regions
with malaria and have a high frequency of neutropenia
[9,10]. Historically, Europeans had a relatively mild expo-
sure to P. falciparum and their mean neutrophil count and
the prevalence of neutropenia (0.8%) are also low. A third
observation in support of malaria hypothesis is a direct
correlation between the age-specific mortality from
Pedigree of families with benign neutropenia Figure 6
Pedigree of families with benign neutropenia. The 
numbers are the lowest absolute neutrophil counts 
recorded. Filled square and circle indicates the presence of 
neutropenic trait in male and female, respectively.
Mean neutrophil count (MNC) in selected ethnic groups by  age Figure 7
Mean neutrophil count (MNC) in selected ethnic 
groups by age. MNC for Mexicans, Europeans and Africans 
is from reference 2.BMC Blood Disorders 2009, 9:3 http://www.biomedcentral.com/1471-2326/9/3
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malaria and the age-specific prevalence of BN. Mortality
from malaria is highest in the first five years of life when
the prevalence of neutropenia appears to be highest [2].
The mechanism by which a low neutrophil count could
provide a survival advantage in malarial infections is
unclear. Neutrophils are charged with multiple toxic mol-
ecules which could direct destructive processes in the
brain and lungs which are the most common causes of
deaths due P. falciparum [20]. Thus, a lower neutrophil
and monocyte count found in subjects with BN may be
associated with fewer deaths from malaria by causing a
less destructive tissue reaction.
Conclusion
The mean neutrophil count in Arabs is lower than in indi-
viduals of European origin. This is the consequence of a
high prevalence of BN, a genetic condition which may
have an autosomal dominant mode of transmission.
These findings may be extrapolated to other Arab socie-
ties; we contend that a high prevalence of BN is the conse-
quence of adaptation to endemic malaria. BN may result
in several adverse consequences if not classified as
'benign'; therefore, using a lower neutrophil count to
define neutropenia would prevent many of these undesir-
able effects. However, this may cause potential problems
in Arab subpopulations with an inherently higher neu-
trophil count. Thus, a potential solution to this problem
is screening the population for neutropenia. Progress in
high throughput sequencing technology, and a more
refined and extended pedigree analysis may allow the
identification of genetic alterations responsible for the dif-
fering neutrophil counts in the Arab population. This may
eventually reveal novel pathways controlling homeostasis
of neutrophils and facilitate development of clinical
guidelines for dealing with BN.
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